Skip to main content
Caplight Logo









Novostia

Novostia

Private
EpalingesHealthcare & Life Scienceshttps://novostia.com/

Last Round

VC Round

Sep 17, 2024

Total Funding Raised

$8.18M

Company Overview

Novostia SA is a medical device company developing an innovative artificial heart valve designed to not require lifelong anticoagulant medication.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

artificial heart valveprosthetic heart valveheart valve replacementmedical deviceMedTechnon-thrombogenic valveanticoagulant-freepolymer heart valveclinical-stage companyaortic valve replacementmitral valve replacementcardiovascular devicebiocompatible polymerimplantable device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novostia Comparables

Compare Novostia with similar companies based on industry and business-model similarity.

Novostia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Foldax Inc.
88%
Xeltis
80%
Corcym
76%

Novostia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 17, 2024
Series AMay 2, 2023
Series AMay 1, 2023
GrantJan 14, 2020
VC RoundFeb 22, 2019

Novostia Investors

Notable investors and investment history

Novostia investors
InvestorRounds
European Innovation Council FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Web traffic grew 115% MoM (from 313 to 673 monthly visitors)

  • May 1, 2023

    $2.7M round raised

Novostia Filings

Explore SEC and related filing metadata, where available.

Novostia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novostia's valuation, stock price, and market status.

Is Novostia a public or private company?

Novostia is a private company.

What is the current stock price of Novostia?

Novostia is a private company with no public stock price. No recent secondary market data is available.

How much is Novostia worth (valuation)?

Valuation information for Novostia is not publicly available.

Can I buy Novostia stock?

Novostia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novostia's last funding round?

Novostia's most recent funding round was VC Round on September 17, 2024.

Who are the main investors in Novostia?

Key investors in Novostia include European Innovation Council Fund.

Will Novostia IPO soon?

No public IPO plans have been announced for Novostia.

How can I track Novostia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novostia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range6
Year Founded2017
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?